tumors
Consultant and Director of the Fellowship Program in Oncology at King Fahd Medical City, Chairman of the Local Supervisory Committee of the Fellowship of Oncology in the Central and Eastern Region, Dr. Abdullah Khalaf Al-Tuwairqi, confirmed that a number of medical authorities in the Kingdom have begun to provide immunotherapy, which has proven effective for the treatment of oncology patients, as an native to chemotherapy. .
Dr. Al-Tuwairqi explained that immunotherapy works to stimulate the immune system in the body and enhance its capabilities to fight various types of tumors, and recent studies have proven the ability of this treatment to control the disease for long periods and achieve high cure rates with the least possible side effects compared to traditional chemotherapy.
He added during a medical lecture on the sidelines of the European Society of Medical Oncology conference in Copenhagen, Denmark: “Immunotherapy helps the body’s immune system to identify cancer cells and then target them, and clinical trials and research have shown the efficiency of this type of treatment, as well as its side effects.” least and its widest range of use.
He noted that the most common tumors in the Kingdom according to the National Cancer Registry include: breast, colorectal, blood, lymphatic, lung and thyroid tumors, while colorectal tumors are the most common among men, while breast tumors are the most prevalent among females.
